Topical levamisole hydrochloride therapy attenuates experimental murine allergic rhinitis

European Journal of Pharmacology

Volumn 577, Issue 1-3, 2007, Pages 162-169

  Wang, Heyao ^a   Zhang, Jiali ^a   Gao, Chunsheng ^b   Zhu, Ying ^a   Wang, Chen ^a   Zheng, Wenjie ^c  

^a Department of Pharmacology ^*  (China)

^b BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

^c BEIJING INSTITUTE OF TECHNOLOGY   (China)

Author keywords

(Mouse); Allergic rhinitis; Eosinophil; Levamisole hydrochloride

Indexed keywords

BUDESONIDE; CYTOKINE; GAMMA INTERFERON; HISTAMINE; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; LEVAMISOLE; MESSENGER RNA; OVALBUMIN;

ALLERGIC RHINITIS; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; EDEMA; EOSINOPHIL; GENE EXPRESSION; INFLAMMATION; MALE; MOUSE; NEWBORN; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; SCORING SYSTEM; UPREGULATION;

ADMINISTRATION, INTRANASAL; ALUMINUM HYDROXIDE; ANIMALS; ANTI-ALLERGIC AGENTS; BORDETELLA PERTUSSIS; COLORING AGENTS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EOSINOPHILS; HISTAMINE; HISTAMINE RELEASE; IMMUNOGLOBULIN E; IMMUNOHISTOCHEMISTRY; INDICATORS AND REAGENTS; INTERLEUKIN-12; LEVAMISOLE; MALE; MICE; MICE, INBRED BALB C; NAPHTHALENESULFONATES; NASAL MUCOSA; OVALBUMIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHINITIS, ALLERGIC, PERENNIAL;

EID: 35448971500     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.08.023     Document Type: Article

References (33)

1. Bagga A., and Mantan M. Nephrotic syndrome in children. Indian. J. Med. Res. 122 (2005) 13-28
2. Barnes P.J. Cytokine-directed therapies for the treatment of chronic airway diseases. Cytokine. Growth. Factor. Rev. 14 (2003) 511-522
3. Bjermer L., and Diamant Z. Current and emerging nonsteroidal anti-inflammatory therapies targeting specific mechanisms in asthma and allergy. Treat. Respir. Med. 3 (2004) 235-246
4. Bjornsdottir U.S., and Cypcar D.M. Asthma: an inflammatory mediator soup. Allergy 54 (1999) 55-61
5. Bousquet J., Van Cauwenberge P., Khalttaev N., and Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J. Allergy. Clin. Immunol. 108 (2001) S147-S334
6. Carlson J.R., Bryant M.L., Hinrichs S.H., Yamamoto J.K., Levy N.B., Yee J., Higgins J., Levine A.M., Holland P., and Gardner M.B. AIDS serology testing in low- and high-risk groups. Jama 253 (1985) 3405-3408
7. Chervinsky P., Casale T., Townley R., Tripathy I., Hedgecock S., Fowler-Taylor A., Shen H., and Fox H. Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis. Ann. Allergy. Asthma. Immunol. 91 (2003) 160-167
8. Farraj A.K., Harkema J.R., and Kaminski N.E. Allergic rhinitis induced by intranasal sensitization and challenge with trimellitic anhydride but not with dinitrochlorobenzene or oxazolone in A/J mice. Toxicol. Sci. 79 (2004) 315-325
9. Flood-Page P.T., Menzies-Gow A.N., Kay A.B., and Robinson D.S. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am. J. Respir. Crit. Care. Med. 167 (2003) 199-204
10. Gulliver T., and Eid N. Effects of glucocorticoids on the hypothalamic-pituitary-adrenal axis in children and adults. Immunol. Allergy. Clin. North. Am. 25 (2005) 541-555
11. Kim K.T., Rabinovitch N., Uryniak T., Simpson B., O'Dowd L., and Casty F. Effect of budesonide aqueous nasal spray on hypothalamic-pituitary-adrenal axis function in children with allergic rhinitis. Ann. Allergy. Asthma. Immunol. 93 (2004) 61-67
12. Kirmaz C., Bayrak P., Yilmaz O., and Yuksel H. Effects of glucan treatment on the Th1/Th2 balance in patients with allergic rhinitis: a double-blind placebo-controlled study. Eur. Cytokine. Netw. 16 (2005) 128-134
13. Lorenz W., Thon K., Neugebauer E., Stoltzing H., Ohmann C., Weber D., Schmal A., Hinterlang E., Barth H., and Kusche J. Reliability and practicability of the fluorometric-fluoroenzymatic histamine determination in pathogenetic studies on peptic ulcer: detection limits and problems with specificity. Agents. Actions 21 (1987) 1-25
14. McKnight A.J., Barclay A.N., and Mason D.W. Molecular cloning of rat interleukin 4 cDNA and analysis of the cytokine repertoire of subsets of CD4+ T cells. Eur. J. Immunol. 21 (1991) 1187-1194
15. Micallef M.J., Ohtsuki T., Kohno K., Tanabe F., Ushio S., Namba M., Tanimoto T., Torigoe K., Fujii M., Ikeda M., Fukuda S., and Kurimoto M. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur. J. Immunol. 26 (1996) 1647-1651
16. Nakanishi K., Yoshimoto T., Tsutsui H., and Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19 (2001) 423-474
17. Naylor P.H., and Hadden J.W. T cell targeted immune enhancement yields effective T cell adjuvants. Int. Immunopharmacol. 3 (2003) 1205-1215
18. Ohta K., and Yamashita N. Apoptosis of eosinophils and lymphocytes in allergic inflammation. J. Allergy. Clin. Immunol. 104 (1999) 14-21
19. Ono S.J., Nakamura T., Miyazaki D., Ohbayashi M., Dawson M., and Toda M. Chemokines: roles in leukocyte development, trafficking, and effector function. J. Allergy. Clin. Immunol. 111 (2003) 1185-1199
20. Pan Z.Z., Parkyn L., Ray A., and Ray P. Inducible lung-specific expression of RANTES: preferential recruitment of neutrophils. Am. J. Physiol. Lung. Cell. Mol. Physiol. 279 (2000) L658-L666
21. Sajid M.S., Iqbal Z., Muhammad G., and Iqbal M.U. Immunomodulatory effect of various anti-parasitics: a review. Parasitology 7 (2005) 1-13
22. Salib R.J., Drake-Lee A., and Howarth P.H. Allergic rhinitis: past, present and the future. Clin. Otolaryngol. 28 (2003) 291-303
23. Sampson A.P. IL-5 priming of eosinophil function in asthma. Clin. Exp. Allergy 31 (2001) 513-517
24. Scheinfeld N., Rosenberg J.D., and Weinberg J.M. Levamisole in dermatology: a review. Am. J.Clin. Dermatol. 5 (2004) 97-104
25. Strait R.T., Morris S.C., Smiley K., Urban Jr. J.F., and Finkelman F.D. IL-4 exacerbates anaphylaxis. J. Immunol. 170 (2003) 3835-3842
26. Tarzi M., and Larche M. Peptide immunotherapy for allergic disease. Expert. Opin. Biol. Ther. 3 (2003) 617-626
27. Togias A. Unique mechanistic features of allergic rhinitis. J. Allergy. Clin. Immunol. 105 suppl (2000) S599-S604
28. Waddell A.N., Patel S.K., Toma A.G., and Maw A.R. Intranasal steroid sprays in the treatment of rhinitis: is one better than another?. J. Laryngol. Otol. 117 (2003) 843-845
29. Whiteland J.L., Shimeld C., Nicholls S.M., Easty D.L., Williams N.A., and Hill T.J. Immunohistochemical detection of cytokines in paraffin-embedded mouse tissues. J. Immunol. Methods 210 (1997) 103-108
30. Wong C.K., Zhang J., Ip W.K., and Lam C.W. Intracellular signal transduction in eosinophils and its clinical significance. Immunopharmacol. Immunotoxicol. 24 (2002) 165-186
31. Ying S., Meng Q., Smith S.J., Larché M., Robinson D.S., and Kay A.B. Methods for identifying human eosinophils in blood and tissue. Allergy. Clin. Immunol. Int: J World Allergy Org. 14 (2002) 64-71
32. Yoshimoto T., Okamura H., Tagawa Y.I., Iwakura Y., and Nakanishi K. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells. Proc. Natl. Acad. Sci. USA 94 (1997) 3948-3953
33. Zimmermann N., Hershey G.K., Foster P.S., and Rothenberg M.E. Chemokines in asthma: cooperative interaction between chemokines and IL-13. J. Allergy. Clin. Immunol. 111 (2003) 227-242